Skip to content

NETTUNIT - Italy-Tunisia Cross-border Environmental network_2

NETTUNIT - Italy-Tunisia Cross-border Environmental network_2

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05186896
Enrollment
1000
Registered
2022-01-11
Start date
2021-06-01
Completion date
2023-03-03
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk Perception

Brief summary

The study involves the development and validation of a questionnaire for risk perception to be administered to residents of areas declared to be at high risk of environmental crisis in the areas of Caltanissetta (Italy) and Tunis (Tunisia). The questionnaire will be administered twice, at baseline and after 1 month.

Interventions

OTHERRisk perception questionnaire

A questionnaire for risk perception will be developed and administered

Sponsors

Istituto per la Ricerca e l'Innovazione Biomedica
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Individuals aged 20-90 years of both sex, living in the areas of Caltanissetta (Italy) and Tunis (Tunisia).

Exclusion criteria

* Individuals with learning difficulties.

Design outcomes

Primary

MeasureTime frameDescription
Construct validity of the questionnaire score at baseline administrationBaseline administrationThe ability of the questionnaire score at baseline to differentiate between sub-samples that are known or expected to differ
Construct validity of the questionnaire score 1 month after the baseline administration1 month after the baseline administrationThe ability of the questionnaire score 1 month after the baseline administration to differentiate between sub-samples that are known or expected to differ
Repeatability of the questionnaire score between the first (baseline) and second (1 month) administrationBaseline administration and 1 month after the baseline administrationThe extent to which the answer distribution will be similar between the two administrations

Countries

Italy

Contacts

Primary ContactStefania La Grutta, MD
stefania.lagrutta@irib.cnr.it0916809194

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026